ARENA PHARMACEUTICALS INC's ticker is ARNA and the CUSIP is 040047607. A total of 172 filers reported holding ARENA PHARMACEUTICALS INC in Q1 2018. The put-call ratio across all filers is 0.43 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2021 | $7,156,000 | -29.1% | 76,993 | -54.6% | 0.25% | -27.8% |
| Q3 2021 | $10,089,000 | -49.1% | 169,424 | -41.7% | 0.35% | -46.2% |
| Q2 2021 | $19,814,000 | -3.5% | 290,533 | -1.9% | 0.65% | -4.8% |
| Q1 2021 | $20,542,000 | -13.4% | 296,038 | -4.1% | 0.68% | -17.4% |
| Q4 2020 | $23,727,000 | +188.0% | 308,828 | +180.4% | 0.83% | +126.3% |
| Q3 2020 | $8,238,000 | -36.1% | 110,151 | -60.9% | 0.36% | -36.1% |
| Q3 2019 | $12,888,000 | -43.4% | 281,577 | -27.5% | 0.57% | -36.9% |
| Q2 2019 | $22,773,000 | +30.8% | 388,418 | 0.0% | 0.90% | +29.7% |
| Q1 2019 | $17,413,000 | +17.0% | 388,418 | +1.7% | 0.70% | +0.4% |
| Q4 2018 | $14,879,000 | -17.4% | 382,010 | -2.4% | 0.70% | +14.1% |
| Q3 2018 | $18,017,000 | +3.0% | 391,510 | -2.4% | 0.61% | -3.9% |
| Q2 2018 | $17,498,000 | +15.2% | 401,330 | +4.4% | 0.63% | +6.6% |
| Q1 2018 | $15,186,000 | – | 384,450 | – | 0.60% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Prosight Management, LP | 163,133 | $7,467,000 | 4.14% |
| PFM Health Sciences, LP | 2,271,536 | $103,968,000 | 3.07% |
| Partner Investment Management, L.P. | 28,877 | $1,322,000 | 2.26% |
| Atika Capital Management LLC | 181,000 | $8,284,000 | 1.74% |
| DAFNA Capital Management LLC | 93,942 | $4,300,000 | 1.62% |
| Asymmetry Capital Management, L.P. | 16,272 | $745,000 | 1.60% |
| First Light Asset Management, LLC | 190,838 | $8,735,000 | 1.32% |
| Perceptive Advisors | 953,129 | $43,624,000 | 1.18% |
| Rhenman & Partners Asset Management AB | 155,000 | $7,094,000 | 0.89% |
| Opus Point Partners Management, LLC | 9,770 | $447,000 | 0.81% |